MedPath
NMPA Approval

Eltrombopag Olamine For Suspension

国药准字H20249763

December 17, 2024

Drug Information

艾曲泊帕乙醇胺干混悬剂

口服混悬剂

25mg(按C₂₅H₂₂N₄O₄计)

化学药品

December 17, 2024

Company Information

Applicant Company

山东省淄博市高新区鲁泰大道1号生物医药创新园D座4楼

Manufacturing Company

长沙市浏阳经济技术开发区健康大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

艾曲泊帕乙醇胺干混悬剂 - NMPA 批准文号 | MedPath